SIREN : 798067872
ALMAVIVA SANTE is a French company founded 12 years ago, specialized in the sector Activités des sociétés holding. Based in AIX-EN-PROVENCE (13540), this company of category ETI shows in 2024 a revenue of 17 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 600 € | 18 865 € | 20 022 € | N/C | 4 588 € | 157 832 € | 347 287 € | 457 033 € | 157 185 € |
| Net income | 9 206 386 € | 14 749 811 € | 43 515 081 € | -4 235 684 € | -6 679 261 € | 9 555 221 € | -3 264 875 € | 15 185 833 € | 1 391 307 € |
| EBITDA | -166 095 € | -147 149 € | -394 435 € | -661 835 € | -496 459 € | -89 235 € | 149 504 € | -3 556 762 € | -1 561 330 € |
| Net margin | 55460.2% | 78186.1% | 217336.3% | N/C | -145581.1% | 6054.0% | -940.1% | 3322.7% | 885.1% |
In 2024, ALMAVIVA SANTE achieves revenue of 17 k€. Revenue is declining over the period 2016-2024 (CAGR: -24.5%). Significant drop of -12% vs 2023. After deducting consumption (0 €), gross margin stands at 17 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -166 k€, representing -1000.6% of revenue. Warning negative scissor effect: despite revenue change (-12%), EBITDA varies by -13%, reducing margin by 220.6 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 9.2 M€, i.e. 55460.2% of revenue. This profit can be retained or distributed to shareholders.
16 600 €
16 600 €
-166 095 €
-174 829 €
9 206 386 €
-1000.6%
The debt ratio (= Financial debt / Equity x 100) stands at 83%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
82.664%
54.681%
-25291.205%
-47.592
50.8%
In 2024, the debt ratio of ALMAVIVA SANTE (82.66) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of ALMAVIVA SANTE (54.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of ALMAVIVA SANTE (-47.59) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 40669.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
40669.156
-6624.541
In 2024, the liquidity ratio of ALMAVIVA SANTE (40669.16) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of ALMAVIVA SANTE (-6624.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 254 days. Excellent situation: suppliers finance 254 days of the operating cycle (retail model). Overall, WCR represents 1961158 days of revenue, i.e. 90.4 M€ to permanently finance. Over 2016-2024, WCR increased by +428%, requiring additional financing.
90 431 183 €
0 j
254 j
0 j
1961158 j
Based on 54 transactions of similar company sales
in 2024,
the value of ALMAVIVA SANTE is estimated at
5 382 253 €
(range 3 432 618€ - 27 509 987€).
The price/revenue ratio is 0.59x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ALMAVIVA SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of ALMAVIVA SANTE in 2024 is 17 k€.
Yes, ALMAVIVA SANTE generated a net profit of 9.2 M€ in 2024.
The headquarters of ALMAVIVA SANTE is located in AIX-EN-PROVENCE (13540), in the department Bouches-du-Rhone.
The tax return of ALMAVIVA SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ALMAVIVA SANTE operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.